Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
Status:
Recruiting
Trial end date:
2022-04-15
Target enrollment:
Participant gender:
Summary
This is a multicentre, single-arm, phase II study to investigate the safety and antiemetic
efficacy of Akynzeo (a fixed dose combination of palonosetron and netupitant) plus
dexamethasone in patients receiving concomitant chemo-radiotherapy with weekly cisplatin for
at least five weeks.